Skip to main content

Table 1 Oligo-DNA microarray analysis of cytokine genes that exhibited a ± 2.0 fold change in expression level between the left (uninjured) and right (injured) brain hemispheres (4 h post-injury).

From: NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats

Gene Name

Gene Bank #

PBBI

Regulation (fold change)

NNZ-2566/PBBI Regulation (fold change)

Chemokine (C-C motif) ligand 2

NM_031530

↑ 21.2

↑ 4.0

Chemokine (C-X-C motif) ligand 2

NM_053647

↑ 20.0

↑ 4.6

Interleukin 6

NM_012589

↑ 12.4

↑ 5.1

Interleukin 1 beta

NM_031512

↑ 11.9

↑ 2.8

Interleukin 1 alpha

NM_017019

↑ 7.0

↑ 32

Interleukin 1 receptor, type II

NM_053953

↑ 6.8

↑ < 2 (1.1)

Chemokine (C-X-C motif) ligand 10

NM_139089

↑ 3.2

↑ 2.3

Chemokine (C-C motif) ligand 3

NM_013025

↑ 3.0

↑ 2.3

Interleukin 4 receptor

NM_133380

↑ 2.8

↑ < 2

Chemokine (C-C motif) ligand 20

NM_019233

↑ 2.7

↑ < 2 (1.0)

Interleukin 6 receptor

NM_017020

↑ < 2 (1.1)

↓ 2.4

CREB binding protein

NM_133381

↑ < 2 (1.1)

↓ 2.0

Lymphotoxin A

NM_080769

↓ 2.2

↓ < 2 (1.9)

Fibroblast growth factor receptor 3

NM_053429

↓ < 2 (1.5)

↓ 2.1

Transforming growth factor alpha

NM_012671

↓ < 2 (1.1)

↓ 2.2

  1. The results of the microarray were quantified using GEArray Expression Analysis Suite. Data are pooled from 6 rats per group and expressed as folds over uninjured brain hemisphere.